Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare type of blood cancer that starts in your plasma cells.

Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for ...

Gene therapy stocks are transforming healthcare with revolutionary treatments. Therefore, as this sector continues to evolve, ...

Brenda Keeter has spent decades giving back to the Monticello community. And now the community wants to give back to her.

Panelists discuss how CARTITUDE-4 demonstrated superior progression-free survival and overall response rates with ...

Explore the future of organ transplants and how biotech innovations like 3D bioprinting and stem cells can solve the organ ...

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study. The new approach, which ...

Hany Elmariah, MD, discussed the safety profile of fedratinib and its evolving role in the post-transplant setting for patients with myeloproliferative neoplasms.

Aplastic anemia is a bone marrow failure process that presents with pancytopenia and bone marrow hypoplasia/aplasia.It ...

In this video, Stephen M. Ansell, MD, PhD professor of medicine, chair of the division of hematology, co-leader of the hematological malignancies program, and interim chair of the department of ...

Doctors are hoping a clinical trial at Harris Health Ben Taub will prove the treatment works and it’s worth getting ...

Findings from the implanted scaffold led researchers to block specific inflammatory molecules, easing disease severity in a ...